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Abstract
Autism is a highly variable brain developmental disorder and has a strong genetic basis. Pax6 is a pivotal player in brain
development and maintenance. It is expressed in embryonic and adult neural stem cells, in astrocytes in the entire central
nervous system, and in neurons in the olfactory bulb, amygdala, thalamus, and cerebellum, functioning in highly context-
dependent manners. We have recently reported that Pax6 heterozygous mutant (rSey
2/+) rats with a spontaneous mutation
in the Pax6 gene, show impaired prepulse inhibition (PPI). In the present study, we further examined behaviors of rSey
2/+
rats and revealed that they exhibited abnormality in social interaction (more aggression and withdrawal) in addition to
impairment in rearing activity and in fear-conditioned memory. Ultrasonic vocalization (USV) in rSey
2+ rat pups was normal
in male but abnormal in female. Moreover, treatment with clozapine successfully recovered the defects in sensorimotor
gating function, but not in fear-conditioned memory. Taken together with our prior human genetic data and results in other
literatures, rSey
2/+ rats likely have some phenotypic components of autism.
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Introduction
Autism is a highly variable developmental brain disorder
defined by three core symptoms with onset prior to 3 years of
age: atypical social behavior; disrupted verbal and non-verbal
communication; and unusual patterns of highly restricted interests
and repetitive behaviors [1–4]. In addition to the major symptoms,
there are several associated emotional manifestations in autism,
such as depression and increased anxiety and fear [5–7].
Furthermore, the concept of autism itself has been broadened
and now includes the group of syndromes referred to as pervasive
developmental disorders including Asperger’s disorder, pervasive
developmental disorder not otherwise specified, childhood disin-
tegrative disorder, and Rett’s disorder in the Diagnostic and Statistical
Manual of Mental Disorders IV [4]. Collectively, these disorders are
known as the autism spectrum disorders (ASD). The existence of
multiple symptom domains and the spectrum of related disorders
demonstrate the complexity of the autism phenotype.
Several twin studies indicate that concordance rates for
monozygotic twins (70–90%) are several-fold higher than those
for dizygotic twins (210%) [2,8–10]. These indicate that genetic
factors play important roles in its etiology. However, the
identification of susceptibility genes has been hindered by the
heterogeneity of the syndrome, insufficient numbers of analyzed
samples and small effect size of each risk gene, compared to other
physical complex disorders [11]. Under these circumstances, to
search for rare risk variants with substantial effects may be a
fruitful approach [12].
Autism is psychiatric illnesses in which complicated information
processing might be disturbed at different levels of brain
development, introducing substantial heterogeneity [13]. Funda-
mental differences in the underlying neurodevelopmental disrup-
tions probably lead to the heterogeneity in both symptoms and
developmental course that are characteristic of autism. Various
genes operate to form the brain through neurogenesis, gliogenesis,
area formation and neuronal circuit formation. Pax6 gene encodes a
transcription factor that is essential for neurodevelopment, and is
expressed in restricted regions of the forebrain, hindbrain, and
spinal cord appearing as early as at embryonic day 8.5 (E8.5) and
throughout life in certain brain regions such as the amygdala,
olfactory bulb, pyriform cortex, and dentate gyrus and also in
astrocytes [14–17]. Human PAX6 gene is originally identified in
chromosomal region 11p13 as one related with WAGR (Wilm’s
tumor, Aniridia, Genitourinary malformations and mental Retar-
dation)syndrome[18,19], whichis a rare genetic disordercausedby
chromosomal deletion of the 11p12-p14 region. The majority of
WAGR patients have mental retardation and behavioral problems,
and importantly, more than 20% of the patients also have features
of autism [20,21]. Recent studies have identified PAX6 mutations in
individuals who manifest mental retardation, aniridia and autism
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21[22–24]. Furthermore, chromosome 11p13, on which PAX6 is
located,isimplicatedasa possiblelocusforautismsusceptibilitybya
linkage study [25]. These accumulating lines of evidence suggest
that PAX6 mutations display concomitant phenotypes of autism.
Recently, our group has carried out resequencing analysis of the
gene in autistic patients with aniridia, with the aim of searching for
additional mutations of PAX6, which might be associated with the
disease. As a result we have detected a novel missense mutation of
PAX6 in an autistic patient, not found in 2,120 non-autistic subjects
[26]. These suggest that a part of autistic patients carry rare PAX6
mutations and that Pax6 dysfunction during neurodevelopment
might be responsible for autistic behaviors.
To address this issue using experimental animals in the current
study, we performed the detailed analyses of rSey
2/+ rats that have
spontaneous nonsense mutations in the Pax6 gene [27,28], in
terms of behavioral tests, biochemical analysis and pharmacolog-
ical examination.
Results
Abnormal exploratory behavior toward a novel
environment in rSey
2/+ rats
rSey
2/+ rats were fertile and showed no change in sexual
behavior and litter size compared with the wild type rats (WT).
Apparently, rSey
2/+ rats exhibited no ataxia or seizure, and moved
normally as judged from their footprint patterns (data not shown).
To assess whether rSey
2/+ rats display autistic phenotypes, we
executed several behavioral testes using only male rats to avoid
potential influence of menstrual cycles except for USV test.
Firstly we conducted open-field tests using a box equipped with
photobeam sensors given a 15 minutes session [29,30]. In this test,
no significant differences were observed in times spent in
locomotion, distances of locomotion, speed of movement and
times spent in the central and peripheral zone of the open field
(Fig. 1A–C, data not shown). However rearing activity was
significantly lower in rSey
2/+ rats than in WT (two-way analysis of
variance (ANOVA) with repeated measures (genotype 6 time);
main effect of factor ‘genotype’: F(1)=6.54, P,0.02; Fig. 1D).
The result suggests that rSey
2/+ rats may be less exploratory or
more anxious to their novel environment [31,32].
To assess the level of anxiety in rSey
2/+ rats, we next carried out
a light-dark (LD) choice test [33]. rSey
2/+ rats spent more time in
the light side of the test box than that WT did (two-way ANOVA
with repeated measures (genotype 6 time); main effect of factor
‘genotype’: F(1)=7.06, P,0.02; Fig. 2A). In addition, the number
of entries into the dark box was increased in rSey
2/+ rats compared
with that of WT (two-way ANOVA with repeated measures
(genotype 6 time); main effect of factor ‘genotype’: F(1)=6.02,
P,0.02; Fig. 2B). Because rodents prefer the dark environment,
rSey
2/+ rats might be less anxious. However, we have to bear in
mind that rSey
2/+ rats have eye defects such as decreased eye size,
and various levels of cataract and iris hyperplasia, though these
phenotypic variation seems to be less than those in Sey mice [34].
rSey
2/+ rats could discriminate a difference between lightness and
darkness since the time percentages spent in the light and dark
sides were not equal. Anyway, the results of LD test should be
interpreted with caution.
To further examine emotional behavior in rSey
2/+ rats, we
performed forced swim test [35]. There were no differences
between WT and rSey
2/+ rats in immobility times at 1st and 2nd
trials of the tests (Fig. 2C, D). Taken altogether, it is reasonable to
assume that impaired rearing activity in rSey
2/+ rats may not be
related to increased anxiety or depressed state but rather to a less
exploratory phenotype.
Abnormality in social interactions in rSey
2/+ rats
A critical component in a model animal of autism is a
quantitative measure of appropriate social interaction. To address
this issue, we examined social interactions of WT and rSey
2/+ rats
by measuring time spent in locomotion, aggression, following,
passive body contact, allo-grooming, mounting, sniffing, and
isolation (WT, 14 pairs; rSey
2/+ rats, 16 pairs).
At 14–17 week-old, rSey
2/+ rats clearly showed more aggressive
behavior than WT (t-test; P,0.01; Fig. 3A), while the former
showed less following behavior than the latter (t-test; P,0.01;
Fig. 3A). There were no differences in the other behaviors
(locomotion, passive body contact, allo-grooming, mounting,
sniffing and isolation). Interestingly, these features became much
more obvious at full adult stages (36–40 weeks). rSey
2/+ rats of
these ages still showed aggressive behavior, although aged WT rats
never did (t-test; P,0.001; Fig. 3B). Moreover, rSey
2/+ rats
exhibited significantly less following (t-test; P,0.05; Fig. 3B) and
passive body contact behaviors (t-test; P,0.01; Fig. 3B). Thus
rSey
2/+ rats clearly exhibited abnormalities in social interaction;
they were more aggressive at fighting and less interested in a
strange partner.
Abnormality in fear-conditioned memory in rSey
2/+ rats
Next we examined performance in memory of rSey
2/+ rats.
Because behavioral tasks requiring visual function may be
influenced by potential visual impairment in rSey
2/+ rats due to
eye abnormalities, we chose a tone fear-conditioning test using
acoustic stimuli in a context-independent way [36]. For condi-
tioning, an electrical shock (0.3 mA) was given just after 20 s tone
(Fig. 4A). Although freezing response immediately after the foot
shock (Fig. 4A) was not different between WT and rSey
2/+ rats,
the latter exhibited significantly reduced freezing response 48 h
(two-way ANOVA with repeated measures (genotype 6 time);
main effect of factor ‘genotype’: F(1)=9.20, P,0.01; Fig. 4B),
and 96 h (two-way ANOVA with repeated measures (genotype 6
time); main effect of factor ‘genotype’: F(1)=11.40, P,0.005;
Fig. 4C) after the initial training session. Since auditory ability
and electric foot shock sensitivity may affect freezing responses, we
performed auditory threshold test (Fig. 4D) and shock sensitivity
test (Fig. 4E). There were no differences in auditory threshold for
orienting sound source and shock sensitivity. Therefore, rSey
2/+
rats had low performance in the context-independent tone-fear
conditioned memory.
Abnormality in ultrasonic vocalization test
Next we tested communicative behavior of rSey
2/+ rats by
recording isolation-induced USV [37] of male postnatal day 7 (P7)
rat pups that were separated from their dams. Number of
ultrasonic calls (Fig. 5A), and mean duration of calls (Fig. 5B),
latency to start calling (Fig. 5C), and peak frequency (Fig. 5D)
were not different between WT and rSey
2/+ male rat pups,
suggesting that communicative behavior of rSey
2/+ male rats was
normal. We also conducted USV test on rSey
2/+ female rat pups
since they were not yet influenced by sexual cycles. It is of note
that rSey
2/+ female rat pups emitted fewer calls than WT (two-way
ANOVA measures (genotype 6 gender); interaction: F(1)=4.20,
P,0.05; main effect of factor ‘genotype’: F(1)=10.53, P,0.002;
not significant main effect of factor ‘gender’; Fig. 5B). These
results imply that rSey
2/+ rat female pups exhibit less property
toward their mothers as similarly observed in autistic infants. This
finding is quite interesting since we reported an autistic girl who
has a mutation in the PAX6 gene inherited from her father who is
not diagnosed as autism [26].
Pax6 Mutant Rat as an Autism Model
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of rSey
2/+ rats
Although the relationship between autism and abnormal
serotonin (5-HT) levels is still unclear, an imbalance of 5-HT
concentrations in brain and/or in blood is believed to cause many
of the characteristic symptoms of autism [38–40]. We measured
platelet-poor-plasma (PPP) 5-HT levels in adult male rats (18–20
weeks) using high-performance liquid chromatography (HPLC)
equipped with an electrochemical detection system. As shown in
Fig. 6A, PPP 5-HT levels in rSey
2/+ male rats were lower than in
WT (t-test: P,0.05). We also measured the 5-HT level in the
hippocampus. Intriguingly, 5-HT level in the rSey
2/+ hippocam-
pus was marginally reduced compared to that in WT (t-test:
P=0.083; Fig. 6B).
Anti-psychotic drug recovers PPI
One goal to establish a rodent model for mental diseases is to
use it for discovery of new drugs for therapy. As described above,
rSey
2/+ rats showed several phenotypes related to autism together
with impairment of PPI [41]. In addition, 5-HT levels were
abnormal in the brain and serum of rSey
2/+ rats. Therefore, we
tested effects of clozapine, an anti-psychotic drug that targets both
5-HT receptor and dopamine receptor D4 [42]. WT and rSey
2/+
rats at 12–16 weeks were intraperitoneally treated either with
saline (control) or with clozapine (1.5 mg/kg body weight) 30 min
before behavior tests. Interestingly, rSey
2/+ rats treated with
clozapine improved scores of PPI (t-test: P,0.05; Fig. 7A). In
marked contrast, clozapine-treated rSey
2/+ rats showed no
recovery on rearing behavior and on tone-fear conditioned
memory at 48 h and 96 h (data not shown). Moreover, clozapine
had no effects on foot shock sensitivity and acoustic startle
response (data not shown). These results suggest that clozapine is
effective to improve sensorimotor deficits in rSey
2/+ rats but does
not alter other behavioral phenotypes.
Discussion
In this study, we examined whether and/or how much Pax6
heterozygous rats model autism. Pax6 homozygous mutant mice/
rats, in which Pax6 functions are completely lost, die at birth with
severe defects in the formation of the eyes, nose, forebrain, and
spinal cord [see review by [43]]. There is a case report describing
that a fetus with compound homozygous mutations in PAX6 gene
exhibits similar congenital defects [44]. On the other hand, Pax6
heterozygous mice/rats are viable and fertile, and show slight
defects in formation of the eyes, olfactory bulb and cerebrum
[34,45–47]. In human, haploinsufficiency of PAX6 causes the
absence or hypoplasia of the anterior commissure, decreased
volumes of the corpus callosum and smaller brain size, in addition
to aniridia and various eye abnormalities [48–52]. In addition,
11p12-13 locus covering PAX6 gene is suggested as one of the
autism linkage loci [25], and we have previously reported a
mutation in PAX6 found in a autistic patient [26]. These data
suggest that PAX6 haploinsufficiency may give rise to subtle
abnormality in brain structures, which may lead to developmental
Figure 1. General motor activity of WT and rSey
2/+ rats in an open-field test. Time spent in locomotion (A), distance of locomotion (B),
speed of movement (C), rearing counts (D) were measured in WT (blue, n=22) and rSey
2/+ rats (magenta, n=28). rSey
2/+ rats exhibited decrease in
the number of rearing compared to WT (genotype: F(1)=6.54, P,0.02; time: F(5)=17.13, P,0.001; genotype 6 time: F(5)=3.74, P,0.005; D),
although time spent in locomotion (A), distance of locomotion (B), and speed of movement (C) were not significantly changed. Data are expressed
by mean 6 SEM. n.s., not significant ***P,0.001, compared to WT as determined by Bonferroni post hoc test.
doi:10.1371/journal.pone.0015500.g001
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2/+ rats. Anxious-like behavior was evaluated using a LD test. The mean
percentage of time spent in the light compartment (A) and the number of transitions between the two compartments (B) were measured in WT
(blue, n=23) and rSey
2/+ rats (magenta, n=28). rSey
2/+ rats spent longer time in the light compartment (genotype: F(1)=7.06, P,0.02; time:
F(3.86)=6.91, P,0.001: genotype6time: F(3.86)=0.56, not significant; A) and exhibited more number of transitions between the two compartments
(genotype: F(1)=6.02, P,0.02; time: F(3.41)=5.56, P,0.001; genotype 6 time: F(3.41)=0.49, not significant; B), compared to WT. Depressive-like
behavior was evaluated using a forced swim test. Immobility time was calculated in first trial of test (C) and in second trial performed 24 h after the
first trial (D). Immobility times were not changed between WT (blue, n=11) and rSey
2/+ rats (magenta, n=16). Data are expressed by mean 6 SEM.
n.s., not significant ***P,0.001, compared to WT as determined by Bonferroni post hoc test.
doi:10.1371/journal.pone.0015500.g002
Figure 3. Social interaction test in WT and rSey
2/+ rats. Time spent for social behaviors, including locomotion, aggression, following, passive
body contact, allo-grooming, mounting, sniffing and isolation were measured in WT and rSey
2/+ rats using an open-field box (A, B). A pair of WT
(blue, 14 pairs) or a pair of rSey
2/+ rats (magenta, 16 pairs) at 14–17 weeks old was placed in an open-field box. rSey
2/+ rats exhibited more aggressive
behavior and less following compared with WT (A). A pair of WT (blue, 12 pairs) or a pair of rSey
2/+ rats (magenta, 13 pairs) at 36–40 weeks old also
exhibited more aggressive behavior but less following. In addition, decreased passive body contact was observed (B). Data are expressed by mean 6
SEM. *P,0.05, **P,0.01, ***P,0.001, compared to WT as determined by t-test.
doi:10.1371/journal.pone.0015500.g003
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rSey
2/+ rats indeed displayed some behavioral abnormalities and
5-HT system deficits related to autism.
Comparison of phenotypes between rSey
2/+ rats and
conditional Pax6 KO mice
In a recent study, conditional Pax6 knockout mice (Pax6
fl/fl;
Emx1-Cre mutants; Pax6 cKO mice) in which Pax6 expression was
completely and specifically abolished in the cortex and hippocam-
pus were generated [53]. They exhibit drastically severe cortical
deficits such as loss of upper layers and prefrontal cortex markers,
which are not seen in human autism. These Pax6 cKO mice
demonstrated a decreased locomotor activity and ataxia due to
defects in motor performance and prefrontal deficits, whereas
locomotor activity of rSey
2/+ rats was normal. Intriguingly,
phenotypes of recent memory and extinction of cued fear that are
relatedtoamygdalafunctions,aredifferentbetweenPax6cKOmice
and rSey
2/+ rats. It is considered that Pax6 function may be normal
in the Pax6 cKO amygdala because promoter activity of Emx1 is not
Figure 4. Tone-fear conditioned memory in WT and rSey
2/+ rats. For training, each rat was placed in the test chamber for 2 min, and
subsequently received a pair of tone (20 s, horizontal bar) and foot shock (0.3 mA, arrow) (A). The mean percentage of time spent freezing was
plotted in WT (blue, n=22) and rSey
2/+ rats (magenta, n=28). Forty-eight h (B) and 96 h (C) after the training, freezing responses to the tone were
measured for 5 min (horizontal bars) in a context-independent way. Freezing response was not different between WT (n=22) and rSey
2/+ rats (n=28)
during the initial training (A). In contrast, performance of tone-fear conditioned memory was lower after 48 h (genotype: F(1)=9.20, P,0.01; time:
F(2.35)=5.92, P,0.005; genotype 6time: F(2.35)=0.25, not significant; B) and 96 h (genotype: F(1)=11.40, P,0.005; time: F(2.62)=7.96, P,0.001;
genotype 6time: F(2.62)=0.99, not significant; C)i nrSey
2/+ rats. Auditory ability (D) and sensitivity to electric foot shock (E)i nrSey
2/+ rats were
comparable to that in WT. Data are expressed by mean 6 SEM. n.s., not significant **P,0.01, ***P,0.001, compared to WT as determined by
Bonferroni post hoc test.
doi:10.1371/journal.pone.0015500.g004
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the amygdala are deemed to be decreased in rSey
2/+ rats. As
expected, this amygdala-dependent cued-fear conditioned recent
memory is normal in Pax6 cKO mice but impaired in rSey
2/+ rats.
PPI that reflects the sensorimotor gating system is reported to be
abnormal across neuropsychiatric disorders including autism [55] and
Asperger’s disorder [56]. PPI scores were not changed in both Pax6
cKO mice and rSey
2/+ rats at juvenile. Interestingly, rSey
2/+ rats
exhibited decreased PPI at 12 weeks and afterwards [41]. These results
may mean that impaired Pax6 functions could elicit altered inhibitory
control of sensory input which is not obvious in younger animals.
Sex differences in impairment of USV in rSey
2/+ rats
Abnormal reciprocal social interactions and communication
deficits are the two of the three diagnostic symptoms of autism
Figure 5. Ultrasonic vocalization in WT and rSey
2/+ rat pups. The USV of individual rat pups (WT male: n=18; WT female: n=9; rSey
2/+ male:
n=11; rSey
2/+ female: n=13) were measured during the isolation condition on P7. Spectrograms (frequency, kHz6time, s) of USV produced by WT
(Upper) and rSey
2/+ male pups (Lower)( A). Column graphs comparing among WT male (closed blue line), rSey
2/+ male (closed magenta line), WT
female (hatched blue line) and rSey
2/+ female (hatched magenta line) pups in the number of calls per trial (B), mean duration of one call (s) (C),
latency of the first vocalization (s) (D), and the peak frequency (kHz) (E). rSey
2/+ female rats exhibited decrease in the number of calls compared to WT
female rats (genotype: F(1)=10.53, P,0.002; gender: F(1)=1.87, not significant; genotype 6gender: F(1)=4.20, P,0.05; B). Data are expressed by
mean 6 SEM. **P,0.01, compared to WT female rats as determined by Bonferroni post hoc test.
doi:10.1371/journal.pone.0015500.g005
Pax6 Mutant Rat as an Autism Model
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15500[57]. One well-characterized method for apparent social commu-
nicative interactions in rodents is the USV emitted by pups when
they are out of the nest. Low levels of this type of infant
vocalization may be relevant to the statements by some parents
that their autistic children seldom cried and were easy to raise
[58]. In literature, several autism models with mutations in Foxp2,
Nlgn4, and Tsc2 exhibit reduced USV [59–61]. Here we detected
unusual properties of vocalizations in only female rSey
2/+ rat pups.
These results might suggest that female rSey
2/+ rats exhibit
impaired communication, which is the second core symptom of
autism. Clinical and epidemiological studies on autism indicate
that the disease incidence is higher in boys than in girls (ratio 4:1),
although the reason is not clear [see review by [62]]. It is known
that girls with autism evidence greater communication deficits
than boys, while boy sufferers show more restricted, repetitive, and
stereotyped behaviors than girls [62,63]. Hence, it seems that there
are sex differences in pathogenic mechanisms. It is of note that
there are sex-dependent differences in the hippocampal 5-HT
transporter levels and dendritic spine densities [64–66]. Further
work is needed to reveal detailed pathogenic mechanisms of sex-
dependent phenotypic differences seen in rSey
2/+ rats.
Altered 5-HT levels and PPI in rSey
2/+ rats
Several studies have demonstrated high levels of 5-HT in whole
blood or platelets in approximately 25–30% of autistic patients
[see review by [67]]. Given that 99% of circulatory 5-HT are
accumulated in platelets, the measurement of platelet-poor plasma
(PPP) 5-HT is essential for the evaluation of ‘free’ 5-HT, since this
may reflect amount of brain synaptic 5-HT. In the present study,
we found decreased 5-HT levels both in PPP and in the
hippocampus of rSey
2/+ rats, representing the first rodent model
that shows impaired 5-HT conditions. Although there are few
reports on PPP 5-HT levels in autistic adults, one paper has
reported that lower PPP 5-HT levels might relate to the
pathophysiology and symptomatology of autism [68].
Pharmacological studies suggest differential roles of 5-HT
receptor subtypes in the modulation of PPI [69,70]. 5-HT2A
receptor (HTR2A) is widely expressed in the central nervous
system [71]. Elevated HTR2A activation by 5-HT could potently
attenuate PPI [72]. Interestingly, we showed recovery of impaired
PPI in rSey
2/+ rats using acute administration of clozapine, an
anti-psychotic drug that shows strong binding to HTR2A [73] and
decreases HTR2A mRNA [74]. We consider that HTR2A
expression might increase in compensation to decreased 5-HT
levels in synaptic clefts, which might induce impaired PPI in
rSey
2/+ rats.
In summary, rSey
2/+ rats may potentially be used for discovery
of effective drugs for autism, because these animals mimic at least
some phenotypes of the disease.
Methods
Animals
Large colonies of rSey
2/+ rats and wild type Sprague-Dawley
(SD) rats (littermates of rSey
2/+ rats) were maintained in Tohoku
University Graduate School of Medicine and in Yamanouchi
Pharmaceutical Company. All rats were maintained with a 12/12
light cycle (lights on at 8:00 am) under temperature (22–24uC) and
humidity (50–60%) controlled conditions. Food and water were
available ad libitum. All the behavioral tests were conducted
between 13:00 and 18:00 h. One week before the beginning of
behavioral tests, the rats were housed one per cage and were
handled once a day for 5 days. Genotype of rSey
2/+ rats was
externally distinguishable because they have eye defects [27]. Age-
Figure 6. Reduced serotonin concentration in rSey
2/+ rats. Contents of 5-HT in PPP (A) and the hippocampus (B) were analyzed by using HPLC
equipped with an electrochemical detection system. 5-HT levels in PPP of rSey
2/+ rats (magenta, n=8) were lower than in WT (blue, n=9) (t-test;
P,0.05, A), while 5-HT level in the hippocampus of rSey
2/+ rats (magenta, n=5) was marginally reduced compared to that in WT (blue, n=6) (t-test;
P=0.83, B). Data are expressed by mean 6 SEM. n.s., not significant *P,0.05, compared to WT as determined by t-test.
doi:10.1371/journal.pone.0015500.g006
Figure 7. Clozapine recovers PPI defect in rSey
2/+ rats. Both WT
and rSey
2/+ rats were injected intrapenitorially either with saline (WT:
closed blue line, n=11; rSey
2/+ rat: closed magenta line, n=11, A)o r
clozapine (WT: hatched blue line, n=11; rSey
2/+ rat: hatched magenta
line, n=11, 1.5 mg/kg body weight, hatched line, A) 30 min prior to
each test. Clozapine treatment specifically recovered the defect in PPI
with 120 dB startle stimulus (t-test; P,0.05, A). Data are expressed by
mean 6 SEM. *P,0.05, compared to WT as determined by t-test.
doi:10.1371/journal.pone.0015500.g007
Pax6 Mutant Rat as an Autism Model
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used in this study. All the animal experiments were carried out in
accordance with the National Institute of Health guidance for the
care and use of laboratory animals and were approved by The
Committees for Animal Experiments in Tohoku University
Graduate School of Medicine (21–252), Mitsubishi Kagaku
Institute of Life Sciences (MITILS-00-003) and RIKEN (H19-
2B109).
General activity test
General activity was measured in an open-field box
(80680640 cm) made of gray vinyl chloride plates as described
previously [30]. The apparatus was placed in a sound-attenuating
room where external noise was greatly reduced (245 dB at
500 Hz). Two pairs of 767 array infrared photosensors were
attached to the outer wall equally spaced in lower and upper rows
at intervals of 2 cm and 4.5 cm above the floor. The lower row of
photocells was used to measure locomotor activity and the upper
row to detect rearing behavior. A computer recorded the number
of horizontal photobeam interruptions caused by animal move-
ment. Each rat at 12–15 weeks old was placed into the apparatus
and remained for 30 min.
Social behavior recording
A pair of WT or a pair of rSey
2/+ rats were placed in an open-
field box (80680640 cm) and behavior of the two rats were video
recorded for 15 min. Recorded behavior was analyzed by
measuring periods for various types of behavior. The aggressive
behaviors (aggression) were kicking, wrestling, and defeating.
Locomotion and isolation indicate that both animals behaved
independently with movement and rest, respectively. Passive body
contact indicates that both animals rested in contact with each
other. The other behaviors were following, allo-grooming,
mounting, and sniffing the partner. The scoring was carried out
by an observer blind to the genotype. A blind observer manually
measured time spent in each categorized behavior.
Light–dark choice test
The apparatus consisted of two compartments made of gray
vinyl choloride plates and placed in a darkened and sound-
attenuating room. One compartment was a bright (250 lux)
chamber (40680640 cm) illuminated by a white bulb (100 W)
and the other was a dark (0.5 lux) chamber (40680640 cm). The
two compartments were separated by a wall and connected by a
small opening (8620 cm) through which the photobeams of the
sensors passed. A rat at 13–16 weeks old was placed in the center
of the light chamber, and its behavior was recorded for 30 min.
The rat was considered to have entered a new area when all four
feet were in this area. The following behavioral measures were
scored: the times spent in the light and dark compartments, the
number of transitions between the two compartments, and the
latency of the initial movement from the light to the dark room.
Forced swim test
Forced swim test was performed as described [75]. On the first
day of the test, each rat at 17–20 weeks old was placed and kept in
the water for 12 min. The test was carried out in a cylindrical
plexiglass tank (40 cm high and 30 cm in diameter), filled with
water (2561uC) up to a level of 20 cm. On the second day, 24 h
later, the rat was placed in the tank for 12 min. After each swim
session, the rat was dried gently with paper towel and returned to
its home cage. These trials were videotaped for later analysis. The
rat’s movement during the swim test was measured using an
infrared sensor system with a multi-Fresnel lens (CompACT FSS
system, Muromachi, Tokyo, Japan) which was placed 20 cm
directly above the surface of the water. The sensor monitors
movement by detecting any object with a temperature 5uC higher
than background within the tank. Behavior in the tank was scored
every second as either swimming or immobility by a computer on
the criteria of movement counts detected by the sensor.
Immobility was defined as less than one movement count per
second, which was approximately the same level that a trained
observer judged as immobility while viewing the videotape. The
time spent in immobility was calculated every minute.
Tone-fear conditioning test
Fear conditioning was carried out as described [30] with minor
modifications. On the training day, each rat was placed in a
triangular prismatic chamber (SGS 002, Muromachi, Tokyo,
Japan) for 2 min, and given a single conditioning trial consisting of
a 20 s of a 65 dB tone at 1,000 Hz (conditioned stimulus) that
ended at the same time as a 0.3 mA, 1 s-foot shock (unconditioned
stimulus). The trained rats at 16–20 weeks old were removed from
the chamber 2 min after the foot shock and returned to their home
cages. Forty-eight h or 96 h after the training, the rats were placed
into a different square chamber in a different room, and 2 min
later the same tone was sounded for 5 min without a foot shock.
The amount of fear conditioned to the tone was assessed by
scoring freezing behavior.
Auditory threshold test
Rats at 17–21 weeks old were placed in the conditioning
chamber for 1 min and were then given 3 s tones (1,000 Hz and
3,000 Hz) of increasing sound intensity. The interval between
tones was 10 s. We determined the threshold of sound level
required to elicit the orienting reflex to the sound source.
Electric shock sensitivity test
For the last of the behavioral tests, we measured the sensitivity
of rats at 17–21 weeks old to footshock. In this test, each rat was
placed in the conditioning chamber and received 1 s shocks of
increasing intensity. The interval between shocks was 25 s. The
sequence of the current used was as follows: 0.05 mA, 0.08 mA,
0.1 mA, 0.2 mA, 0.3 mA, 0.4 mA, 0.5 mA, 0.6 mA and 0.8 mA.
We determined the minimal level of current required to elicit the
following stereotypical responses: flinching, running, vocalization,
and jumping. These experiments were performed blindly.
Measurement of ultrasonic vocalizations
A total of 51 rat pups (WT male; 18, WT female; 9, rSey
2/+
male; 11, rSey
2/+ female; 13) born to 4 dams were tested in USV
during the isolation condition on P7. At first, we removed a dam
from the home cage. To maintain the pups’ body temperature, the
home cage was placed on a heat pad maintained at 35uC. A pup
was transported in a plastic chamber (17062806130 cm) with
absorbent cotton which was placed in a soundproof box and
vocalizations were recorded for 5 min.
USV was recorded with a condenser microphone (CM16/
CMPA, Avisoft Bioacoustics, Berlin, Germany) connected to an
amplifier/digitizer (Avisoft UltraSoundGate416H, Avisoft Bio-
acoustics, Berlin, Germany) at a sampling rate of 250 kHz with
125 kHz low-pass filter. The recorded files were transferred to a
sound analysis software (SASLab Pro ver. 4.52, Avisoft
Bioacoustics, Berlin, Germany) for fast Fourier transform (512
FFT-length, 100% frame size, Hamming window, 50% time
window overlap). We analyzed the number of calls, mean
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each call.
Measurement of 5-HT concentration
Blood (2 ml) at 18–20 weeks old was taken from the abdominal
vein and drawn into test tubes containing sodium fluoride and
EDTA-2Na (Becton Dickinson, Tokyo, Japan), and immediately
placed on ice. PPP was separated by centrifugation of the blood
samples at 1,5006g for 15 min at 4uC. The resulting PPP (800 ml)
was collected and stored at 280uC till assayed. 5-HT analyses of
the PPP samples were conducted within 1 week after the
experiment. PPP samples (100 ml) were added to 100 mlo f
0.5 M perchloric acid and 10 ml of 0.1 mM isoproterenol as an
internal standard. After vortex-mixing, the tubes were centrifuged
at 2,0006g and 4uC for 15 min, and 40 ml of the resulting
supernatant was then injected into the HPLC system, equipped
with a reverse-phase chromatographic column (Eicompak, SC-
5ODS, 3 mm diameter6150 mm, Eicom, Kyoto, Japan). The
applied potential was +400 mV versus the Ag/AgCl electrode.
The mobile phase consisted of a 0.1 M sodium phosphate buffer
(pH 6.0)-methanol (8 : 2, v/v) containing 400 mg/L sodium 1-
octanesulfonate and 50 mg/L EDTA-2Na. The flow rate was set
at 0.5 ml/min and the column temperature was maintained at
25uC. Compounds were detected using an electrochemical
detector (Eicom ECD-300, Eicom, Kyoto, Japan) and quantitated
by comparison of peaks area to that of the internal standard [76].
Hippocampus samples at 12 weeks old were homogenized in 5
volumes of 0.2 M perchloric acid containing 0.1 M EDTA and
the proper concentration of isoproterenol. After centrifugation of
the homogenates, the pH of the supernatant was adjusted to 3.0 by
adding 1 M sodium acetate. The mobile phase was 0.1 M sodium
citrate, 0.1 M citric acid, 0.5 mM sodium octanesulfonate,
0.15 mM EDTA, and 12% methanol, pH 3.5 [77].
Measurement of auditory startle and prepulse inhibition
of acoustic startle
Rats at 12–17 weeks old were tested in a startle chamber (SR-
Lab Systems, San Diego Instruments, San Diego, CA) positioned
within a soundproof cabinet in a sound-attenuating room
according to the method previously described [78,79]. A constant
background noise of 65 dB was presented throughout the test. To
measure PPI scores rats were given 20-ms-long 68, 71, or 77 dB
prepulse that preceded the 120 dB pulse (40 ms width) by 100 ms
(pp68, pp71, pp77). Percent PPI of a startle response was
calculated: 100 – [(startle response on acoustic prepulse and
startle stimulus trials/startle response alone trials) 6100].
Treatment with clozapine
Rats at 12–17 weeks old were injected intraperitoneally with
0.5 mg/ml of clozapine (Sigma) to make the final dose at 1.5 mg/
kg body weight or with the similar amount of saline (control)
according to the body weight. Both rats were analyzed for the
same behavior tests as described above.
Data analysis
Data were analyzed by Student’s t test, two-way ANOVA or
two-way ANOVA with repeated measures followed by Bonferroni
post hoc where appropriate, using SPSS version 16 software (SPSS
Inc., Chicago, IL, USA). A P value below 0.05 was considered to
be significant. All values in the text and figure legends were
expressed as means plus/minus standard error of the mean (SEM),
and n is the number of rats tested except for social interaction test
where n indicates the number of pairs of rats examined.
Acknowledgments
We thank Dr. Kaichi Yoshizaki for critical reading of the manuscript. We
also thank Ms. Michi Otonari and Ms. Sayaka Makino for maintenance of
rSey
2 rat colony; and Ms. Yumi Watanabe for technical assistance.
Author Contributions
Conceived and designed the experiments: KI NO. Performed the
experiments: TU NT RN SI KK KO NO. Analyzed the data: TU NT
SI. Wrote the paper: TU TY KK KO KI NO. Performed experiments:
MM.
References
1. Levy SE, Mandell DS, Schultz RT (2009) Autism. Lancet 374: 1627–1638.
2. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, et al. (1989) A
twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child
Psychol Psychiatry 30: 405–416.
3. Geschwind DH (2009) Advances in autism. Annu Rev Med 60: 367–380.
4. Association AP (2000) Diagnostic and Statistical Manual of Mental Disorders.
edn 4.
5. Ospina MB, Krebs Seida J, Clark B, Karkhaneh M, Hartling L, et al. (2008)
Behavioural and developmental interventions for autism spectrum disorder: a
clinical systematic review. PLoS One 3: e3755.
6. Hughes JR (2009) Update on autism: a review of 1300 reports published in 2008.
Epilepsy Behav 16: 569–589.
7. Senju A, Johnson MH (2009) Atypical eye contact in autism: models,
mechanisms and development. Neurosci Biobehav Rev 33: 1204–1214.
8. Ronald A, Happe F, Bolton P, Butcher LM, Price TS, et al. (2006) Genetic
heterogeneity between the three components of the autism spectrum: a twin
study. J Am Acad Child Adolesc Psychiatry 45: 691–699.
9. Dworzynski K, Happe F, Bolton P, Ronald A (2009) Relationship between
symptom domains in autism spectrum disorders: a population based twin study.
J Autism Dev Disord 39: 1197–1210.
10. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al. (1995) Autism
as a strongly genetic disorder: evidence from a British twin study. Psychol Med
25: 63–77.
11. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R (2010) Genetics of
autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry
19: 169–178.
12. Becker KG (2004) The common variants/multiple disease hypothesis of
common complex genetic disorders. Med Hypotheses 62: 309–317.
13. Bill BR, Geschwind DH (2009) Genetic advances in autism: heterogeneity and
convergence on shared pathways. Curr Opin Genet Dev 19: 271–278.
14. Walther C, Gruss P (1991) Pax-6, a murine paired box gene, is expressed in the
developing CNS. Development 113: 1435–1449.
15. Stoykova A, Gruss P (1994) Roles of Pax-genes in developing and adult brain as
suggested by expression patterns. J Neurosci 14: 1395–1412.
16. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, et al. (2002)
Regeneration of hippocampal pyramidal neurons after ischemic brain injury by
recruitment of endogenous neural progenitors. Cell 110: 429–441.
17. Sakurai K, Osumi N (2008) The neurogenesis-controlling factor, Pax6, inhibits
proliferation and promotes maturation in murine astrocytes. J Neurosci 28:
4604–4612.
18. Ton CC, Hirvonen H, Miwa H, Weil MM, Monaghan P, et al. (1991) Positional
cloning and characterization of a paired box- and homeobox-containing gene
from the aniridia region. Cell 67: 1059–1074.
19. Hanson I, Van Heyningen V (1995) Pax6: more than meets the eye. Trends
Genet 11: 268–272.
20. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M (2005) WAGR syndrome: a
clinical review of 54 cases. Pediatrics 116: 984–988.
21. Xu S, Han JC, Morales A, Menzie CM, Williams K, et al. (2008)
Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH
for identifying genes contributing to mental retardation and autism. Cytogenet
Genome Res 122: 181–187.
22. Malandrini A, Mari F, Palmeri S, Gambelli S, Berti G, et al. (2001) PAX6
mutation in a family with aniridia, congenital ptosis, and mental retardation.
Clin Genet 60: 151–154.
23. Davis LK, Meyer KJ, Rudd DS, Librant AL, Epping EA, et al. (2008) Pax6 39
deletion results in aniridia, autism and mental retardation. Hum Genet 123:
371–378.
24. Graziano C, D’Elia AV, Mazzanti L, Moscano F, Guidelli Guidi S, et al. (2007)
A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia,
and mental retardation. Am J Med Genet A 143A: 1802–1805.
Pax6 Mutant Rat as an Autism Model
PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e1550025. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al. (2007)
Mapping autism risk loci using genetic linkage and chromosomal rearrange-
ments. Nat Genet 39: 319–328.
26. Maekawa M, Iwayama Y, Nakamura K, Sato M, Toyota T, et al. (2009) A novel
missense mutation (Leu46Val) of PAX6 found in an autistic patient. Neurosci
Lett 462: 267–271.
27. Osumi N, Hirota A, Ohuchi H, Nakafuku M, Iimura T, et al. (1997) Pax-6 is
involved in the specification of hindbrain motor neuron subtype. Development
124: 2961–2972.
28. Matsuo T, Osumi-Yamashita N, Noji S, Ohuchi H, Koyama E, et al. (1993) A
mutation in the Pax-6 gene in rat small eye is associated with impaired migration
of midbrain crest cells. Nat Genet 3: 299–304.
29. Becker A, Grecksch G, Bernstein HG, Hollt V, Bogerts B (1999) Social
behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative
and qualitative analysis. Psychopharmacology (Berl) 144: 333–338.
30. Ikegami S, Inokuchi K (2000) Antisense DNA against calcineurin facilitates
memory in contextual fear conditioning by lowering the threshold for
hippocampal long-term potentiation induction. Neuroscience 98: 637–646.
31. Bouwknecht JA, van der Gugten J, Groenink L, Olivier B, Paylor RE (2004)
Effects of repeated testing in two inbred strains on flesinoxan dose-response
curves in three mouse models for anxiety. Eur J Pharmacol 494: 35–44.
32. Wells CE, Krikke B, Saunders J, Whittington A, Lever C (2009) Changes to
open field surfaces typically used to elicit hippocampal remapping elicit graded
exploratory responses. Behav Brain Res 197: 234–238.
33. Costall B, Coughlan J, Horovitz ZP, Kelly ME, Naylor RJ, et al. (1989) The
effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.
Pharmacol Biochem Behav 33: 573–579.
34. Kanakubo S, Nomura T, Yamamura K, Miyazaki J, Tamai M, et al. (2006)
Abnormal migration and distribution of neural crest cells in Pax6 heterozygous
mutant eye, a model for human eye diseases. Genes Cells 11: 919–933.
35. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a
new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379–391.
36. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and
hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:
274–285.
37. Branchi I, Santucci D, Alleva E (2001) Ultrasonic vocalisation emitted by infant
rodents: a tool for assessment of neurobehavioural development. Behav Brain
Res 125: 49–56.
38. Anderson GM (2002) Genetics of childhood disorders: XLV. Autism, part 4:
serotonin in autism. J Am Acad Child Adolesc Psychiatry 41: 1513–1516.
39. Anderson GM, Horne WC, Chatterjee D, Cohen DJ (1990) The hyperser-
otonemia of autism. Ann N Y Acad Sci 600: 331–340; discussion 341–332.
40. Huang CH, Santangelo SL (2008) Autism and serotonin transporter gene
polymorphisms: a systematic review and meta-analysis. Am J Med
Genet B Neuropsychiatr Genet 147B: 903–913.
41. Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, et al. (2009)
Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on
prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 4: e5085.
42. Brieden T, Ujeyl M, Naber D (2002) Psychopharmacological treatment of
aggression in schizophrenic patients. Pharmacopsychiatry 35: 83–89.
43. Osumi N (2001) The role of Pax6 in brain patterning. Tohoku J Exp Med 193:
163–174.
44. Glaser T, Jepeal L, Edwards JG, Young SR, Favor J, et al. (1994) PAX6 gene
dosage effect in a family with congenital cataracts, aniridia, anophthalmia and
central nervous system defects. Nat Genet 7: 463–471.
45. Schmahl W, Knoedlseder M, Favor J, Davidson D (1993) Defects of neuronal
migration and the pathogenesis of cortical malformations are associated with
Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta
Neuropathol 86: 126–135.
46. Maekawa M, Takashima N, Arai Y, Nomura T, Inokuchi K, et al. (2005) Pax6 is
required for production and maintenance of progenitor cells in postnatal
hippocampal neurogenesis. Genes Cells 10: 1001–1014.
47. Haba H, Nomura T, Suto F, Osumi N (2009) Subtype-specific reduction of
olfactory bulb interneurons in Pax6 heterozygous mutant mice. Neurosci Res 65:
116–121.
48. Sisodiya SM, Free SL, Williamson KA, Mitchell TN, Willis C, et al. (2001)
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunc-
tion in humans. Nat Genet 28: 214–216.
49. Free SL, Mitchell TN, Williamson KA, Churchill AJ, Shorvon SD, et al. (2003)
Quantitative MR image analysis in subjects with defects in the PAX6 gene.
Neuroimage 20: 2281–2290.
50. Mitchell TN, Free SL, Williamson KA, Stevens JM, Churchill AJ, et al. (2003)
Polymicrogyria and absence of pineal gland due to PAX6 mutation. Ann Neurol
53: 658–663.
51. Hardan AY, Pabalan M, Gupta N, Bansal R, Melhem NM, et al. (2009) Corpus
callosum volume in children with autism. Psychiatry Res 174: 57–61.
52. Nishina S, Kohsaka S, Yamaguchi Y, Handa H, Kawakami A, et al. (1999)
PAX6 expression in the developing human eye. Br J Ophthalmol 83: 723–727.
53. Tuoc TC, Radyushkin K, Tonchev AB, Pinon MC, Ashery-Padan R, et al.
(2009) Selective cortical layering abnormalities and behavioral deficits in cortex-
specific Pax6 knock-out mice. J Neurosci 29: 8335–8349.
54. Guo H, Hong S, Jin XL, Chen RS, Avasthi PP, et al. (2000) Specificity and
efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice. Biochem
Biophys Res Commun 273: 661–665.
55. Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor
gating deficits in adults with autism. Biol Psychiatry 61: 482–486.
56. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, et al.
(2002) Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain
125: 1594–1606.
57. Klin A, Saulnier CA, Sparrow SS, Cicchetti DV, Volkmar FR, et al. (2007)
Social and communication abilities and disabilities in higher functioning
individuals with autism spectrum disorders: the Vineland and the ADOS.
J Autism Dev Disord 37: 748–759.
58. Frith U (1993) Autism. Sci Am 268: 108–114.
59. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, et al.
(2008) Reduced social interaction and ultrasonic communication in a mouse
model of monogenic heritable autism. Proc Natl Acad Sci U S A 105:
1710–1715.
60. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, et al. (2005) Altered ultrasonic
vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad
Sci U S A 102: 9643–9648.
61. Young DM, Schenk AK, Yang SB, Jan YN, Jan LY (2010) Altered ultrasonic
vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad
Sci U S A 107: 11074–11079.
62. Wing L (1981) Sex ratios in early childhood autism and related conditions.
Psychiatry Res 5: 129–137.
63. Hartley SL, Sikora DM (2009) Sex Differences in Autism Spectrum Disorder:
An Examination of Developmental Functioning, Autistic Symptoms, and
Coexisting Behavior Problems in Toddlers. J Autism Dev Disord.
64. McEuen JG, Semsar KA, Lim MA, Bale TL (2009) Influence of sex and
corticotropin-releasing factor pathways as determinants in serotonin sensitivity.
Endocrinology 150: 3709–3716.
65. Shors TJ, Chua C, Falduto J (2001) Sex differences and opposite effects of stress
on dendritic spine density in the male versus female hippocampus. J Neurosci 21:
6292–6297.
66. Wellmann K, Lewis B, Barron S (2010) Agmatine reduces ultrasonic
vocalization deficits in female rat pups exposed neonatally to ethanol.
Neurotoxicol Teratol 32: 158–163.
67. Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin
Pediatr 8: 348–354.
68. Spivak B, Golubchik P, Mozes T, Vered Y, Nechmad A, et al. (2004) Low
platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsycho-
biology 50: 157–160.
69. Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine 1a receptor
agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp
Ther 263: 486–493.
70. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse
inhibition of startle: normal subjects, patient groups, and pharmacological
studies. Psychopharmacology (Berl) 156: 234–258.
71. Van Steenwinckel J, Noghero A, Thibault K, Brisorgueil MJ, Fischer J, et al.
(2009) The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons
in rat lumbar dorsal root ganglia. Neuroscience 161: 838–846.
72. Brauer D, Strobel A, Hensch T, Diers K, Lesch KP, et al. (2009) Genetic
variation of serotonin receptor function affects prepulse inhibition of the startle.
J Neural Transm 116: 607–613.
73. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, et al. (1995) Association
between clozapine response and allelic variation in 5-HT2A receptor gene.
Lancet 346: 281–282.
74. Burnet PW, Chen CP, McGowan S, Franklin M, Harrison PJ (1996) The effects
of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene
expression and serotonin metabolism in the rat forebrain. Neuroscience 73:
531–540.
75. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, et al. (2001)
Mice containing a human chromosome 21 model behavioral impairment and
cardiac anomalies of Down’s syndrome. Hum Mol Genet 10: 1163–1175.
76. Danaceau JP, Anderson GM, McMahon WM, Crouch DJ (2003) A liquid
chromatographic-tandem mass spectrometric method for the analysis of
serotonin and related indoles in human whole blood. J Anal Toxicol 27:
440–444.
77. Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, et al. (2003)
Conditional ablation of striatal neuronal types containing dopamine D2 receptor
disturbs coordination of basal ganglia function. J Neurosci 23: 9078–9088.
78. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, et al. (2000)
Toward understanding the biology of a complex phenotype: rat strain and
substrain differences in the sensorimotor gating-disruptive effects of dopamine
agonists. J Neurosci 20: 4325–4336.
79. Kew JN, Koester A, Moreau JL, Jenck F, Ouagazzal AM, et al. (2000)
Functional consequences of reduction in NMDA receptor glycine affinity in mice
carrying targeted point mutations in the glycine binding site. J Neurosci 20:
4037–4049.
Pax6 Mutant Rat as an Autism Model
PLoS ONE | www.plosone.org 10 December 2010 | Volume 5 | Issue 12 | e15500